ABSTRACT OF INVENTION (19) RU(11) 2 473 346(13) C1: SUBSTANCE: declared invention refers to medicine. The anti-tuberculosis preparations are cancelled, while Ursosal 20 mg/kg is single administered per os, and Enterosgel® 10-15 g for 3 days. Then, a dose of Ursosan is reduced to 12-15 mg/kg a day with underlying reinitiation of the antituberculosis preparations, and the Ursosan therapy is continued until the ALT value appears to be below an upper limit of normal. EFFECT: method under invention enables higher clinical effectiveness in the drug-induced liver injury in children. 1 tbl, 3 dwg, 2 ex
